Searched for
GERMAN PHARMA
What running a business in India actually looks like: Nightmare of CEOs these days is conversion of commercial disputes into criminal casesA corporate crisis manager describes how business disputes in India are increasingly being turned into criminal cases, exposing executives ...- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- SUSE eyes deeper India push as CEO flags growth, open-source demandSUSE plans to increase investments in India, recognizing it as a significant growth market for open-source technologies. The company aims t...
- Assets dip, affiliations shift: Stalin, Udhayanidhi among Tamil Nadu leaders reporting lower wealthM. K. Stalin, Udhayanidhi Stalin and other Dravida Munnetra Kazhagam leaders have reported a decline in declared assets over five years, la...
- Kirti Ganorkar: Why the veteran insider is the right dose for Sun PharmaKirti Ganorkar, a long-time Sun Pharma veteran, will take over as Managing Director from September 1, succeeding founder Dilip Shanghvi, wh...
- DRL's foray into medical cannabis to prompt others' entryIn December, global drug major Pfizer announced its acquisition of Arena Pharma, a medical cannabis company, for $6.7 billion. In May last ...
- Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
- Pharma companies should have clear rules for business in India: GermanyBahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...
- German pharma company Boehringer Ingelheim remains bullish on R&D and India"I am quite convinced that as more and more Indian generic companies start doing their own research, I think it will change the conditions ...
- Dr Reddy's nets Rs 167 crore in Q4Dr Reddy’s Laboratories bounced back into profit for the three months ended March, helped by the absence of any further provisioning for lo...
- Cipla makes cancer drug cheaperCipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.
- Delhi High Court reject German pharma firm pleaThe Delhi High Court has rejected the plea of German pharma company B Braun Melsungen AG claiming patent rights to an item sold by healthca...
- German owner taps options on Dabur Pharma delistingGerman company Fresenius Kabi, which recently acquired Dabur Pharma, is learnt to be exploring the possibility of delisting the company fro...
- German firm Fresenius leads race for Dabur PharmaSources say that Fresenius Kabi is in advanced talks with the Indian company and has valued Dabur Pharma at over Rs 1,000 cr. Corporate Ind...
- Dabur Pharma up on possible selloutShares of Dabur Pharma advanced Thursday on reports that the company is looking at options like inducting a private equity investor as well...
- Dabur Pharma weighing PE partner, outright saleThe Dabur Group is learnt to be evaluating a range of options for determining the future direction of Dabur Pharma, the anti-cancer drug co...
- Foreign players look at India to develop lower-cost drugsGerman pharma major Boehringer Ingelheim is close to completing its first in-licensing deal with an Indian pharmaceutical company.
- Merck inks pact to develop, sell Glenmark diabetes drugGerman pharma major Merck KGaA and Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharma India, announced...
Load More
